Trial Profile
A Phase II Study of GW 786034 (Pazopanib) in Advanced Thyroid Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2021
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 04 Feb 2020 Status changed from active, no longer recruiting to completed.
- 04 Feb 2020 Status changed from active, no longer recruiting to completed.
- 04 Feb 2020 Status changed from active, no longer recruiting to completed.